Renalytix plc
(NASDAQ: RNLX)
|
5:30 PM UTC, 07/03/24 | |||
---|---|---|---|---|
Last: $0.25 | Change: -0.00 | %Change: -1.15% | Volume: 91,841 |
Open: | $ 0.25 | Volume: | 91,841 | |
---|---|---|---|---|
High: | $ 0.25 | Yield(%) | 0.00 | |
Low: | $ 0.25 | P/E Ratio (ttm): | n/a | |
Dividend ($): | n/a | Market Cap ($): | 19.30M | |
EPS ($) | -0.78 | Shares Out: | 77.18M |
% Price Change (last 4 weeks): | -43.96 |
---|---|
% Price Change (last 13 weeks): | -70.26 |
% Price Change (last 26 weeks): | -40.52 |
% Price Change (last 52 weeks): | -91.82 |
% Price Change (year to date): | -35.90 |
Return on Equity (%): | -242.76 |
---|---|
Return on Assets (%): | -113.04 |
Return on Invested Capital (%): | -94.80 |
Gross Profit Margin (%): | 21.16 |
---|---|
Net Profit Margin (%): | -1340.20 |
Operating Profit Margin (%): | -1240.70 |
|
|
50-day Moving Average: | $0.51 |
---|---|
200-day Moving Average: | $0.76 |
Avg. Daily Vol. (last 50 days): | 336,878 |
Avg. Daily Vol. (last 200 days): | 750,651 |
52-wk high: | $4.04 |
52-wk low: | $0.22 |
Bid: | $0.25 |
Ask: | $0.25 |
Renalytix Plc engages in the manufacturing of medical devices and equipment. It includes the development of artificial intelligence-enabled clinical diagnostic solutions for kidney disease. The company was founded by James McCullough on March 15, 2018 and is headquartered in New York, NY.
|
Renalytix plc
1460 Broadway New York NY 10036 Phone: 1.646.397.3970 Fax: n/a http://www.renalytixai.com |
Earnings (1year) ($): | -0.78 |
---|---|
Annual Dividend ($): | 0.00 |
Current P/E Ratio (ttm): | n/a |
Book Value ($): | 0.15 |
Cash Flow ($): | -0.96 |
Price/Earnings (x): | n/a |
---|---|
Price/Sales (x): | 35.27 |
Price/Book (x): | 19.65 |
Price/Cash Flow (x): | n/a |
Quick Ratio (x): | 1.67 |
---|---|
Current Ratio (x): | 1.67 |
LT Debt/Equity (x): | 108.02 |
Total Debt/Equity (x): | 173.95 |